Up-to-date prevalence at recommended ages for discontinuing routine colorectal, cervical and lung cancer screening

Authors:
Publisher website
Google Scholar
Abstract
Cancer screening guidelines specify ages at which routine screening should be discontinued and, except for cervical cancer screening, do not require that specific screening history criteria be met for discontinuation. We estimated the prevalence of being up-to-date with average-risk screening guidelines for colorectal cancer (CRC), cervical cancer, and lung cancer as of the recommended ages for discontinuation of routine screening. We conducted a descriptive study among several US health-care systems during 2010-2019. Up-to-date screening prevalence, based on US Preventive Services Task Force guidelines, was ascertained before the 76th, 66th, and 81st birthdays among persons eligible for CRC screening (n = 316 756 persons), cervical cancer screening (n = 20 282 persons), and lung cancer screening (n = 1151 persons). Up-to-date screening prevalence was 84.4% for CRC, 58.9% for cervical cancer, and 6.3% for lung cancer screening. Up-to-date screening prevalence at the ages recommended for discontinuing routine CRC, cervical cancer, and lung cancer screening varied appreciably and was particularly low for lung cancer screening.
Funding Information
  • National Cancer Institute of the National Institutes of Health (UM1CA221940)
  • National Cancer Institute of the National Institutes of Health (UM1CA222035)
  • National Cancer Institute of the National Institutes of Health (UM1CA221939)
  • National Cancer Institute of the National Institutes of Health (U24CA221936)
  • National Cancer Institute of the National Institutes of Health (K12CA167549)
  • National Cancer Institute of the National Institutes of Health (K99CA277552)

This publication has 18 references indexed in Scilit: